UFC lightweight Gleison Tibau has received a two-year suspension from the U.S. Anti-Doping Agency after failing both in- and out-of-competition drug tests in a two-week span late last year.
In tests conducted on Oct. 23 in Coconut Creek, Fla., and on Nov. 7 in Sao Paulo, Tibau tested postive for erythropoietin (EPO), a synthetic hormone used to stimulate the body’s production of red blood cells and increase oxygen transport and aerobic power. USADA revealed the results of Tibau’s test and the fighter’s punishment on Thursday.
Tibau suspension will be retroactive to Nov. 7, when he submitted Abel Trujillo 1:45 into the opening round at UFC Fight Night “Belfort vs.